NASDAQ · Healthcare · Biotechnology
MBX Biosciences, Inc. Common Stock
MBX
MBX Biosciences, Inc. CEO Peter Kent Hawryluk · Market cap $1.2B.
$36.91
-0.07 · -0.19%
52w hi $45.8552w lo $9.43
Off 52w high 28.8%
62
NOTABLE
Current InsiderScore
Corp · 90d
2
1 buys · 1 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
0 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $55.33
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 08 | Salomon Azoulay | Chief Medical Officer | Sell | 55,000 | $38.38 | −$2.11M | 37 |
| Mar 13 | Kent P. Hawryluk | President & CEO | Buy | 18,500 | $28.41 | +$526K | 62 |
| Oct 20 | Kent P. Hawryluk | President & CEO | Buy | 20,000 | $13.64 | +$273K | 59 |
| Oct 17 | Steven L. Hoerter | Buy | 20,000 | $13.25 | +$265K | 63 | |
| Sep 26 | Patrick J Heron | Buy | 666,666 | $18.00 | +$12.00M | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay